The impact of adoption of a new urate-lowering agent on trends in utilization and cost in practice.

The impact of adoption of a new urate-lowering agent on trends in utilization and cost in practice.

<h4>Objectives</h4>Changes in treatment choice of therapy and size of treated population that can lead to under- or overestimate of payer's budget are less likely to be reassured after reimbursement adoption of a new drug. The aim of this study was to evaluate the effects of febuxos...

Full description

Bibliographic Details
Main Authors: Yueh-Lung Peng, Chien-Te Lee, You-Lin Tain, Yaw-Bin Huang, Hung-Yi Chuang, Yen-Hsia Wen, Shiou-Huei Huang, Chun-Yu Tsai, Chien-Ning Hsu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0221504

Internet

https://doi.org/10.1371/journal.pone.0221504

Similar Items